FDA Brief

Warning letters Devices

FDA warning letter to

Manhattan Stitching Company, Inc.

High riskIssued Apr 13, 2021Posted Jul 6, 2021Center for Devices and Radiological Health

Manhattan Stitching Company sold KN95 and other face masks with COVID-19 claims without FDA approval or clearance.

What happened

FDA reviewed the company’s websites and social media pages on February 11, 2021. It found the company offering KN95 Face Mask, 3-ply Face Mask, and 3-Ply Disposable Youth Face Mask with statements indicating use for COVID-19, without FDA marketing approval, clearance, or authorization. FDA also found a “Certificate of Registration” displayed with the KN95 mask that used the FDA logo and implied FDA approval or endorsement.

What FDA found

  1. FDA says the company offered KN95 and other face masks for COVID-19 use without FDA marketing approval, clearance, or authorization, making them adulterated.

    section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B)
  2. FDA says the company did not give the required premarket notification (510(k)) before introducing the devices into commercial distribution, making them misbranded.

    section 502(o), 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)
  3. FDA says the KN95 mask labeling was false or misleading because a “Certificate of Registration” with the FDA logo implied FDA approval or endorsement.

    section 502(a), 21 U.S.C. § 352(a); 21 CFR 807.39

What FDA wants

FDA asks the company to immediately stop selling any adulterated or misbranded products for COVID-19 and to reply in writing within 15 business days with the steps taken, supporting documents, and a plan to prevent repeat violations.

Who should pay attention

  • online sellers and retailers of imported face masks
  • brands relying on supplier FDA registration certificates
  • distributors of KN95 and disposable masks

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. AseptiKits, LLC

    AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.

    High risk
  2. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  3. Ostar Beauty Sci-Tech Co Ltd.

    FDA warned Ostar Beauty Sci-Tech, a Chinese maker of microneedling pens, LED masks and fat-freezing pads, for selling unapproved medical devices in the US.

    High risk
  4. RoyalVibe Health Ltd.

    RoyalVibe Health marketed unapproved medical devices for cancer and other diseases and refused an FDA inspection.

    High risk